OutcomeImprovementEffect · pTreatmentControl
risk of death
30.3% lower · RR 0.70 · p = 1.00
30.3% lowerRR 0.70p = 1.00
2 of 22 (9.1%)
3 of 23 (13.0%)
treatment 2 of 22 (9.1%), control 3 of 23 (13.0%)NNT 25
recovery time
70.2% lower · relative time 0.30 · p = 0.97
70.2% lowerrelative time 0.30p = 0.97
4.15 [2.98-6.96] n=23
13.91 [5.85-999] n=23
treatment 4.15 [2.98-6.96] n=23, control 13.91 [5.85-999] n=23time to 2 point improvement
recovery time
6.2% higher · relative time 1.06 · p = 0.90
6.2% higherrelative time 1.06p = 0.90
17.0 [9.0-36.0] n=23
16.0 [11.0-24.0] n=23
treatment 17.0 [9.0-36.0] n=23, control 16.0 [11.0-24.0] n=23time to resolution of symptoms
time to discharge
56.7% lower · relative time 0.43 · p = 0.98
56.7% lowerrelative time 0.43p = 0.98
6.03 [3.07-14.89] n=23
13.92 [5.85-999] n=23
treatment 6.03 [3.07-14.89] n=23, control 13.92 [5.85-999] n=23
time to viral-
0.1% lower · relative time 1.00 · p = 1.00
0.1% lowerrelative time 1.00p = 1.00
13.09 [2.87-27.04] n=23
13.1 [2.99-15.1] n=23
treatment 13.09 [2.87-27.04] n=23, control 13.1 [2.99-15.1] n=23